Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05529173 · ClinicalTrials.gov registry record · Phase 4
Povidone-Iodine for Nasal Decolonization
A Phase 4 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 4
- Development phase
- 192
- Enrollment target
NCT05529173 is a Phase 4 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 192 participants.
The verdict
NCT05529173, a Phase 4 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 192 participants
- Enrollment target
Study Summary
To evaluate the efficacy and tolerability of 10% povidone-iodine in eliminating nasal carriage of Staphylococcus aureus and MRSA. To determine whether a more convenient, single-dose, pre-operative 10% povidone-iodine (PI) application is effective in reducing nasal carriage of S. aureus and MRSA. We expect a statistically significant decrease in S. aureus/MRSA colonization in nasal cultures taken perioperatively after intervention in patients who received pretreatment with PI as compared to patients who received normal saline (NS).
Interventions
- DRUG Povidone-Iodine 10%
- DRUG 0.9% NaCl Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2022-09-06 |
| Est. Completion | 2023-11-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05529173
The ClinicalTrials.gov registry entry for NCT05529173 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Povidone-Iodine 10% is the first listed.
NCT05529173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05529173 about?
NCT05529173 is a clinical study titled "Povidone-Iodine for Nasal Decolonization". To evaluate the efficacy and tolerability of 10% povidone-iodine in eliminating nasal carriage of Staphylococcus aureus and MRSA. To determine whether a more convenient, single-dose, pre-operative 10% povidone-iodine (PI) application is effective in reducing nasal carriage of S. aureus and MRSA. We ...
What is the current status of trial NCT05529173?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 192 participants. The study started on 2022-09-06. Estimated completion is 2023-11-17.
What interventions are being tested in trial NCT05529173?
The interventions under investigation include: Povidone-Iodine 10% (DRUG), 0.9% NaCl Solution (DRUG).
Who is sponsoring clinical trial NCT05529173?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.